Literature DB >> 31021267

Bayesian Extended Redundancy Analysis: A Bayesian Approach to Component-based Regression with Dimension Reduction.

Ji Yeh Choi1, Minjung Kyung2, Heungsun Hwang3, Ju-Hyun Park4.   

Abstract

Extended redundancy analysis (ERA) combines linear regression with dimension reduction to explore the directional relationships between multiple sets of predictors and outcome variables in a parsimonious manner. It aims to extract a component from each set of predictors in such a way that it accounts for the maximum variance of outcome variables. In this article, we extend ERA into the Bayesian framework, called Bayesian ERA (BERA). The advantages of BERA are threefold. First, BERA enables to make statistical inferences based on samples drawn from the joint posterior distribution of parameters obtained from a Markov chain Monte Carlo algorithm. As such, it does not necessitate any resampling method, which is on the other hand required for (frequentist's) ordinary ERA to test the statistical significance of parameter estimates. Second, it formally incorporates relevant information obtained from previous research into analyses by specifying informative power prior distributions. Third, BERA handles missing data by implementing multiple imputation using a Markov Chain Monte Carlo algorithm, avoiding the potential bias of parameter estimates due to missing data. We assess the performance of BERA through simulation studies and apply BERA to real data regarding academic achievement.

Entities:  

Keywords:  Bayesian methodology; extended redundancy analysis; missing data; multiple imputation; power prior distribution

Year:  2019        PMID: 31021267     DOI: 10.1080/00273171.2019.1598837

Source DB:  PubMed          Journal:  Multivariate Behav Res        ISSN: 0027-3171            Impact factor:   5.923


  1 in total

1.  A Unified Neural Network Framework for Extended Redundancy Analysis.

Authors:  Ranjith Vijayakumar; Ji Yeh Choi; Eun Hwa Jung
Journal:  Psychometrika       Date:  2022-03-24       Impact factor: 2.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.